Table 1. Clinical characteristic of Triploid detected PGD/S cycles using SNP array.

ID	F_Age	F_K	M_Age	M_K	N(Oocyte)	N(MII)	Days	E_ID	E_ Score	Embryo SNP Karyotype
Cycle 1	28	46,XX	24	46,XY,t(4,7)(p1 6,q22)	11	7	5	1	3BB	arr 4p(p15.31→qter)×3,7p(pter→q22.1)×1,(X)×2
							5	2	3BB	Amplification Failure
							5	3	3BB	arr (1-22)×3,(X)×3
Cycle 2	27	46,XX	27	45,XY,rob(13;1 4)(q10;q10)	9	6	5	1	3BC	arr (1-22)×3,(X)×3
							5	2	2BB	arr 21(pter→qter)×1,(X)×2
							5	3	3BB	arr (1-22)×2,(X)×2
							5	4	4BC	arr (1-22)×2,(XY)×1
Cycle 3	34	46,XX	38	45,XY,rob(14;2 1)(q10;q10)	16	16	5	1	3BB	arr (1-22)×3,(X)×3
							5	2	4AB	arr (1-22)×2,(XY)×1
							5	3	6BB	arr (1-22)×2,(XY)×1
Cycle 4	29	46,XX,t(9,1 7)(p13,q12)	31	46,XY	21	19	5	1	3BB	arr (1-22)×2,(XY)×1
							5	2	4BB	arr 9q(q13→qter)×3,17p-,(X)×2
							5	3	2BB	arr (1-22)×3,(X)×3
							5	4	2BB	arr 9(pter→qter)×3,22 (pter→qter)×1, 17p-,(XY)×1
							5	5	2BC	arr 19p(p13.2→pter)× 1,(X)×2
Cycle 5	27	46,XX,t(11;1 5)(p15.4;q25)	27	46,XY	15	14	5	1	3BB	arr (1-22)×2,(X)×2
							5	2	2BB	arr (1-22)×3,(X)×3
							5	3	3BB	arr 4q(q33→qter)×1, (X)×2
							6	4	5BB	arr 16(pter→qter)×1, (X)×2
							6	5	5BB	arr (1-22)×2, (X)×2
							6	6	6BB	arr (1-22)×2,(X)×2

5 cycles identified triploidy were shown from 218 cycles.

F_Age: Female age, F_K: Female karyotype, M_Age: Male age, M_K: Male karyotype, N(Oocyte): Number of retrieve oocyte, N(MII): Number of MII oocyte, E_ID: Embryo_ID, E_ Score: Embryo Score.